Using a Label-free Proteomics Method to Identify Differentially Abundant Proteins in Closely Related Hypo- and Hypervirulent Clinical Mycobacterium tuberculosis Beijing Isolates
暂无分享,去创建一个
Bernd Thiede | Harald G. Wiker | Robin M. Warren | P. V. van Helden | B. Thiede | R. Warren | G. D. de Souza | H. Wiker | S. Fortuin | Gustavo A. de Souza | Paul D. van Helden | Christopher R. E. McEvoy | Christian J. Koehler | C. McEvoy | Diana Aguilar | Suereta Fortuin | Rogelio Hernandez Pando | D. Aguilar | R. H. Pando | Suereta Fortuin
[1] G. Rook,et al. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection , 1997, Infection and immunity.
[2] Alexander Makarov,et al. Dynamic range of mass accuracy in LTQ orbitrap hybrid mass spectrometer , 2006, Journal of the American Society for Mass Spectrometry.
[3] Yu-Jin Jung,et al. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Gicquel,et al. Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant , 2005, Clinical and experimental immunology.
[5] Priscille Brodin,et al. ESAT-6 proteins: protective antigens and virulence factors? , 2004, Trends in microbiology.
[6] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[7] B. Gicquel,et al. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature‐tagged transposon mutagenesis , 1999, Molecular microbiology.
[8] Tanya Parish,et al. Deletion of Two-Component Regulatory Systems Increases the Virulence of Mycobacterium tuberculosis , 2003, Infection and Immunity.
[9] D. Luchsinger,et al. The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria. , 1980, Stain technology.
[10] Waltraud X. Schulze,et al. A Novel Proteomic Screen for Peptide-Protein Interactions* , 2004, Journal of Biological Chemistry.
[11] D. Frishman,et al. Protein abundance profiling of the Escherichia coli cytosol , 2008, BMC Genomics.
[12] G. Kaplan,et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Reed,et al. Differential Monocyte Activation Underlies Strain-Specific Mycobacterium tuberculosis Pathogenesis , 2004, Infection and Immunity.
[14] M. Mann,et al. Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.
[15] W. Bishai,et al. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set , 2004, Molecular microbiology.
[16] Jonathan Crabtree,et al. Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set , 2006, Journal of bacteriology.
[17] A. Apt,et al. Man and mouse TB: contradictions and solutions. , 2009, Tuberculosis.
[18] Ben Sidders,et al. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis , 2007, Molecular microbiology.
[19] G. Bancroft,et al. The case for hypervirulence through gene deletion in Mycobacterium tuberculosis. , 2008, Trends in microbiology.
[20] R. Fleischmann,et al. Attenuation of Late-Stage Disease in Mice Infected bythe Mycobacterium tuberculosis Mutant Lacking theSigF Alternate Sigma Factor and Identification ofSigF-Dependent Genes by MicroarrayAnalysis , 2004, Infection and Immunity.
[21] M. Mann,et al. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.
[22] D. Saini,et al. Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. , 2004, FEMS microbiology letters.
[23] Peter M Woollard,et al. Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence. , 2002, Microbiology.
[24] D. Sherman,et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. , 2003, The Journal of infectious diseases.
[25] Inge Jonassen,et al. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example , 2008, BMC Genomics.
[26] Tanya Parish,et al. The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. , 2003, Microbiology.
[27] Midori Kato-Maeda,et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Sampieri,et al. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. , 1996, Immunology.
[29] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[30] A. Sampieri,et al. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. , 1997, Immunology.
[31] Winston A Hide,et al. Molecular evolution of Mycobacterium tuberculosis: phylogenetic reconstruction of clonal expansion. , 2001, Tuberculosis.
[32] M. Daffé,et al. Identification of the Missing trans-Acting Enoyl Reductase Required for Phthiocerol Dimycocerosate and Phenolglycolipid Biosynthesis in Mycobacterium tuberculosis , 2007, Journal of bacteriology.
[33] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[34] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[35] P. V. van Helden,et al. A Recently Evolved Sublineage of the Mycobacterium tuberculosis Beijing Strain Family Is Associated with an Increased Ability to Spread and Cause Disease , 2007, Journal of Clinical Microbiology.
[36] Stefan Niemann,et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Brosch,et al. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[38] P. Roholl,et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model , 2004, Clinical and experimental immunology.
[39] G. Mahairas,et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.
[40] G. Kaplan,et al. The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence , 2008, Infection and Immunity.
[41] M. Reed,et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.
[42] C. Bertozzi,et al. A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Lipsitch,et al. Virulence and transmissibility of pathogens: what is the relationship? , 1997, Trends in microbiology.
[44] R. Hernández-Pando,et al. The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis. , 2007, Vaccine.
[45] P. V. van Helden,et al. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. , 2009, Tuberculosis.
[46] M. Mann,et al. Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.
[47] A. L. Sørensen,et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis , 1995, Infection and immunity.
[48] A. Makarov,et al. The Orbitrap: a new mass spectrometer. , 2005, Journal of mass spectrometry : JMS.